Connect. Learn. Grow.
The Early-Stage Innovation Forum (ESIF) remains a cornerstone of AusMedtech, showcasing Australia’s most promising early-stage innovators from universities, hospitals and research institutes. Designed for ideas in their earliest stages, ESIF provides innovators the opportunity to present to an expert advisory panel and receive valuable feedback to help validate their concept, identify gaps, and understand what is needed to progress.
The Early-Stage Innovation Forum is proudly sponsored by
New for 2026: ESIF applications go though IRP
You no longer apply directly for ESIF. Instead, submit your innovation to the AusBiotech’s Investor Readiness Panel (IRP).
The IRP is now accepting applications on a rolling basis. The IRP provides confidential, stage-relative feedback to help life sciences innovators strengthen their translation pathway and funding readiness, from early non-dilutive support through to future capital conversations.
How it works
01
Submit IRP application
(short form + supporting deck/summary)
02
ESIF eligibility check
Submissions that meet ESIF eligibility are progressed for ESIF consideration.
03
Notification
Applicants are notified if invited to present.
What you will receive through a IRP review
Feedback is provided across four lenses (scaled to discovery stage):
- Evidence and rationale (what’s known today)
- Development pathway (what comes next)
- Translation/scalability considerations (as relevant)
- Commercial and capital positioning (who cares / who pays, later-stage view)
Deadline for ESIF AusMedtech 2026
Submissions have now closed.
University, hospital and research institute members (including tech transfer and translational offices) can support the sector by referring suitable discovery teams who are approaching a commercialisation decision, exploring spinout pathways, or preparing for their first external capital conversation.